Showing results (111-120 of 119) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Iscience|June 30, 2022
C910 chemical compound inhibits the traffiking of several bacterial AB toxins with cross-protection against influenza virusYu Wu, Nassim Mahtal, Eléa Paillares, et al.Plos Pathogens|October 31, 2009
High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitorsThierry Christophe, Mary Jackson, Hee Kyoung Jeon, et al.ACS Chemical Biology|November 27, 2014
2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1João Neres, Ruben C Hartkoorn, Laurent R Chiarelli, et al.Molecular Microbiology|September 29, 2016
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteriaVinayak Singh, Neeraj Dhar, János Pató, et al.Science (New York, N.Y.)|March 21, 2009
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesisVadim Makarov, Giulia Manina, Katarina Mikusova, et al.Tuberculosis (Edinburgh, Scotland)|February 3, 2005
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosisAnn Williams, Graham J Hatch, Simon O Clark, et al.Acta Neuropathologica|December 10, 2016
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolismJulien Chapuis, Amandine Flaig, Benjamin Grenier-Boley, et al.Science Translational Medicine|May 4, 2022
The small-molecule SMARt751 reverses Mycobacterium tuberculosis resistance to ethionamide in acute and chronic mouse models of tuberculosisMarion Flipo, Rosangela Frita, Marilyne Bourotte, et al.Nature Medicine|August 6, 2013
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosisKevin Pethe, Pablo Bifani, Jichan Jang, et al.Pageof 12